2026 NPPES data Rheumatology Physician NPI 1144455262 M.D.
Verify on CMS →

BASMA AL NAHLAWI, M.D.

Rheumatology Physician in SAN MARCOS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 379 beneficiaries · Rheumatology Physician avg: 2K
MIPS score
61.6857/100
▼ 21 pts below national avg 83.1 · [object Object]
Industry payments
$3.4K
145 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BASMA AL NAHLAWI, M.D. reported a CMS MIPS final score of 61.6857/100 — below the 83.1 national average — and filed 3,476 Medicare Part D claims in 2023.

61.6857/100
MIPS score · -21 vs avg
3K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BASMA AL NAHLAWI, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

62 6th percentile higher than 6% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BASMA AL NAHLAWI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BASMA AL NAHLAWI, M.D.?

Below national average

NPI registry status

Active

Issued 05/19/2009

NPI 1144455262

Primary specialty

Rheumatology Physician

Mid-sized

6,181 US NPIs in this specialty

Medicare Part D claims

3,476 69% vs specialty avg

2023 prescription claims

Specialty avg: 2,054

MIPS final score

61.6857/100 21.414299999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in California

How Rheumatology Physician compares to other specialties among California providers

California providers

Rheumatology Physician share within California

1. Rheumatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Rheumatology Physician share within California

Medicare quality performance — MIPS

BASMA AL NAHLAWI, M.D.'s 2023 MIPS final score plotted against the Rheumatology Physician national average

Below national average
MIPS Final Score
61.6857/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Rheumatology Physician) — 61.6857/100 vs national avg 83.1

0%100%National avg83%61.7%
MIPS final score (Rheumatology Physician) — 61.6857/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BASMA AL NAHLAWI, M.D. is a Rheumatology Physician provider practicing in SAN MARCOS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1144455262. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

BASMA AL NAHLAWI, M.D. appears in the CMS NPPES registry as a Rheumatology Physician provider holding M.D. credentials at 960 W SAN MARCOS BLVD STE 210, SAN MARCOS, CA, 92078, with a listed phone of (760) 707-6765. NPI 1144455262 was issued on 05/19/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AL NAHLAWI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,476 prescription claims written by this provider, covering 379 Medicare beneficiaries and totaling roughly $2.6 million in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 61.6857/100 for the 2023 performance year (Quality 77.2122, Cost 69.3361), compared with the national average of 83.1.

Rheumatology Physician is a mid-sized specialty nationwide, with 6,181 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

960 W SAN MARCOS BLVD STE 210
SAN MARCOS, CA 92078

Provider Details

NPI 1144455262
Specialty Rheumatology Physician
Credentials M.D.
Gender Female
NPI Issued 05/19/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

61.6857
Final Score
Avg: 83.1
77.2122
Quality
69.3361
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where BASMA AL NAHLAWI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KAYAL MEDICAL GROUP INC
SAN MARCOS, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BASMA AL NAHLAWI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$3.4K

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to BASMA AL NAHLAWI, M.D.. To verify BASMA AL NAHLAWI, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,476
Total Claims
$2.6M
Total Drug Cost
379
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,659
Total Day Supply
134,016
Generic Drug Cost
$109K
Antibiotic Claims
13

Patient Demographics

Average Patient Age
69.7 years
Avg HCC Risk Score
1.62
Gender Split
75% female / 25% male
Age Distribution
<65: 74, 65-74: 204, 75-84: 80, 85+: 21

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydroxychloroquine Sulfate
895
Prednisone
429
Methotrexate
Methotrexate Sodium
403
Allopurinol
225
Leflunomide
214
Folic Acid
179
Diclofenac Sodium
160
Meloxicam
134
Methylprednisolone
78
Mycophenolate Mofetil
44

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Rheumatology Physician Overview

How BASMA AL NAHLAWI, M.D. fits within the Rheumatology Physician landscape nationally.

6,181
Rheumatology Physician Providers in US
52
States with Rheumatology Physician
2,054
Avg Claims per Provider

BASMA AL NAHLAWI, M.D.'s 3,476 claims are above the specialty average of 2,054.

Nearby Rheumatology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as AL NAHLAWI.

Compare Rheumatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BASMA AL NAHLAWI, M.D.'s specialty?
BASMA AL NAHLAWI, M.D. specializes in Rheumatology Physician and practices in SAN MARCOS, California. Credentials: M.D..
How much does BASMA AL NAHLAWI, M.D. prescribe under Medicare Part D?
In 2023, BASMA AL NAHLAWI, M.D. wrote 3,476 Medicare Part D claims totaling $2.6M in drug costs for 379 beneficiaries.
What is BASMA AL NAHLAWI, M.D.'s Medicare quality score?
BASMA AL NAHLAWI, M.D. has a CMS MIPS Final Score of 61.6857/100 (Quality: 77.2122, Cost: 69.3361). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BASMA AL NAHLAWI, M.D. located?
BASMA AL NAHLAWI, M.D. is located at 960 W SAN MARCOS BLVD STE 210, SAN MARCOS, CA, 92078. Phone: (760) 707-6765.
What is BASMA AL NAHLAWI, M.D.'s NPI number?
BASMA AL NAHLAWI, M.D.'s National Provider Identifier (NPI) is 1144455262, issued on 05/19/2009.
How many Rheumatology Physician providers are there in the US?
There are 6,181 Rheumatology Physician providers across 52 states in the US. The average Rheumatology Physician provider writes 2,054 Medicare Part D claims per year.
What drugs does BASMA AL NAHLAWI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, BASMA AL NAHLAWI, M.D.'s most frequently prescribed drugs include Hydroxychloroquine Sulfate, Prednisone, Methotrexate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BASMA AL NAHLAWI, M.D. accept Medicare?
BASMA AL NAHLAWI, M.D. appears in CMS Medicare data with 3,476 Part D claims and 379 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BASMA AL NAHLAWI, M.D.'s credentials?
BASMA AL NAHLAWI, M.D.'s NPI is 1144455262 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology